UK’s CMA Fines Four On Nortriptyline

Accord, Alissa, Lexon And King Fined Over £3.4m In Total

CMA
The CMA has fined four firms over nortriptyline market sharing and information exchange • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation